Reference
Guven DC, et al. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Supportive Care in Cancer 29: 5417-5423, No. 9, Sep 2021. Available from: URL: http://doi.org/10.1007/s00520-021-06139-3
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1869, 44 (2021). https://doi.org/10.1007/s40278-021-00909-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-00909-4